Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Neurophysiological Markers of Language Impairments: a Longitudinal Study on Infants At Familial Risk

NCT05767242 is registered in ClinicalTrials.gov with IRCCS Eugenio Medea as lead sponsor.

NCT NCT05767242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05767242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Neurophysiological Markers of Language Impairments: a Longitudinal Study on Infants At Familial Risk
Lead sponsor
IRCCS Eugenio Medea
Phase
Observational
Overall status
Recruiting
Start date
February 21, 2022
Completion date
December 31, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

development, infant, development, language, developmental language disorder, learning disabilities